deemed to be at-the-market distributions as defined in National Instrument 44-102 -Shelf Distributions (NI 44-102), including sales made directly on the Toronto Stock Exchange (the TSX), the New York Stock
Exchange (NYSE) or other existing trading markets for the Securities. The prices at which the Securities may be offered may vary as between purchasers and during the period of distribution. If, in connection with the offering of
Securities at a fixed price or prices, the underwriters, dealers or agents have made a bona fide effort to sell all of the Securities at the initial offering price fixed in the applicable Prospectus Supplement, the public offering price may be
decreased and thereafter further changed, from time to time, to an amount not greater than the initial public offering price fixed in such Prospectus Supplement, in which case the compensation realized by the underwriters, dealers or agents will be
decreased by the amount that the aggregate price paid by purchasers for the Securities is less than the gross proceeds paid by the underwriters, dealers or agents to the Corporation.
In connection with any offering of Securities, other than an at-the-market
distribution (as defined under applicable Canadian securities legislation), unless otherwise specified in a Prospectus Supplement, the underwriters, dealers or agents, as the case may be, may over-allot or effect transactions which stabilize,
maintain or otherwise affect the market price of the Securities at a level other than those which otherwise might prevail on the open market. Such transactions may be commenced, interrupted or discontinued at any time. A purchaser who acquires
Securities forming part of the underwriters, dealers or agents over-allocation position acquires those securities under this Prospectus and the Prospectus Supplement relating to the particular offering of Securities, regardless of
whether the over-allocation position is ultimately filled through the exercise of the over-allotment option or secondary market purchases. See Plan of Distribution. No underwriter, dealer or agent involved in an at-the-market distribution under this Prospectus, no affiliate of such an underwriter, dealer or agent and no person or company acting jointly or in concert with
such underwriter, dealer or agent will over-allot Securities in connection with such distribution or effect any other transactions that are intended to stabilize or maintain the market price of the Securities.
All information permitted under applicable law to be omitted from this Prospectus will be contained in one or more Prospectus Supplements that will be delivered
to purchasers together with this Prospectus. Each Prospectus Supplement will be incorporated by reference into this Prospectus for the purposes of securities legislation as of the date of the Prospectus Supplement and only for the purposes of the
distribution of the Securities to which such Prospectus Supplement pertains.
This Prospectus constitutes a public offering of the Securities only in those
jurisdictions where they may be lawfully offered for sale and only by persons permitted to sell the Securities in those jurisdictions. The Corporation may offer and sell Securities to, or through, underwriters or dealers and also may offer and sell
certain Securities directly to other purchasers or through agents pursuant to exemptions from registration or qualification under applicable securities laws. A Prospectus Supplement relating to each issue of Securities offered thereby will set forth
the names of any underwriters, dealers, or agents involved in the offering and sale of the Securities and will set forth the terms of the offering of the Securities, the method of distribution of the Securities including, to the extent applicable,
the proceeds to the Corporation and any fees, discounts or any other compensation payable to underwriters, dealers or agents and any other material terms of the plan of distribution.
The outstanding Common Shares are listed on the TSX under the symbol IMG and on the NYSE under the symbol IAG. On August 31, 2022,
the last trading day prior to the date of this Prospectus, the closing price of the Common Shares on the TSX was C$1.57 and the closing price of the Common Shares on the NYSE was $1.19. Unless otherwise specified in the applicable Prospectus
Supplement, the First Preference Shares, the Second Preference Shares, the Debt Securities, the Warrants and the Subscription Receipts will not be listed on any securities exchange. There is no market through which these Securities may be sold and
purchasers may not be able to resell these Securities purchased under this Prospectus. This may affect the pricing of these Securities in the secondary market, the transparency and availability of trading prices, the liquidity of these Securities,
and the extent of issuer regulation. See Risk Factors.
The registered and principal office of the Corporation is located at 401 Bay Street,
Suite 3200, Toronto, Ontario M5H 2Y4.
The Corporation is permitted to prepare this Prospectus in accordance with Canadian disclosure requirements, which
are different from those of the United States. The Corporation prepares its financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board. They may not be comparable to
financial statements of United States companies.
Owning the Securities may subject purchasers to tax consequences both in the United States and
Canada. This Prospectus or any applicable Prospectus Supplement may not describe these tax consequences fully. Purchasers should read the tax discussion in any applicable Prospectus Supplement.
A purchasers ability to enforce civil liabilities under the United States federal securities laws may be affected adversely because the Corporation is
incorporated in Canada, most of its officers and directors and all of the experts named in this Prospectus are not residents of the United States, and all of its assets are located outside of the United States.
Neither the U.S. Securities and Exchange Commission (the SEC) nor any state securities regulator has approved or disapproved these securities, or
determined if this Prospectus is truthful or complete. Any representation to the contrary is a criminal offence.
No underwriter has been involved in
the preparation of this Prospectus nor has any underwriter performed any review of the contents of this Prospectus.
Agent for Service of Process
Ian Ashby, Dr. Ann Masse and Peter OHagan, being directors of the Corporation, reside outside of Canada. Each of Mr. Ashby,
Dr. Masse and Mr. OHagan has appointed the Corporation at 401 Bay Street, Suite 3200, PO Box 153, Toronto, Ontario, M5H 2Y4, as his agent for service of process in Canada. Purchasers are advised that it may not be possible for
investors to enforce judgments obtained in Canada against each of Mr. Ashby, Dr. Masse or Mr. OHagan, even though each of Mr. Ashby, Dr. Masse or Mr. OHagan has appointed an agent for service of process.
Francois J. Sawadogo, Travis J. Manning and R. Breese Burnley being co-authors of the technical report
entitled Technical Report on the Essakane Gold Mine Carbon-In-Leach and Heap Leach Feasibility Study, Sahel Region, Burkina Faso (effective November 6, 2019)
and Alain Mouton and Michel Dromacque being co-authors of the technical report entitled Technical Report on the Rosebel Gold Mine, Suriname (effective December 31, 2021) reside outside of
Canada. Each of Messrs. Sawadogo, Manning, Burnley, Mouton and Dromacque has appointed the Corporation at 401 Bay Street, Suite 3200, PO Box 153, Toronto, Ontario, M5H 2Y4, as his agent for service of process in Canada. Purchasers are advised that
it may not be possible for investors to enforce judgments obtained in Canada against Messrs. Sawadogo, Manning, Burnley, Mouton or Dromacque.